Trulicity 0.75 mg/0.5 mL solution in a single-dose pen Images
Generic Name: dulaglutide
This medication has been identified as Trulicity 0.75 mg/0.5 mL solution in a single-dose pen. It is supplied by Eli Lilly and Company.
Trulicity is used in the treatment of Cardiovascular Risk Reduction; Type 2 Diabetes and belongs to the drug class GLP-1 Agonists (Incretin Mimetics). Risk cannot be ruled out during pregnancy. Trulicity 0.75 mg/0.5 mL solution in a single-dose pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Trulicity
- Generic Name
- dulaglutide
- Strength
- 0.75 mg/0.5 mL solution in a single-dose pen
- Availability
- Prescription only
- Drug Class
- GLP-1 Agonists (Incretin Mimetics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-1433
More about Trulicity (dulaglutide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (970)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: GLP-1 Agonists (Incretin Mimetics)
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.